A Comparative Bioavailability Study of DFD-29 Capsules 40 mg Versus SOLODYN® Tablets 105 mg, Under Fasting & Fed Conditions in Healthy Adult Human Subjects

Clinical trial NCT05452785 · COMPLETED

Trial details

NCT number: NCT05452785
Sponsor: Journey Medical Corporation
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Pharmacokinetics

Start date: 2022-05-07
Primary completion: 2022-05-25
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.